Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease
Open Access
Abstract
Cardiovascular disease is most frequently caused by the development and progression of atherosclerosis. When coronary arteries are afflicted, and the stenoses caused by atherosclerotic plaques are severe enough, the metabolic supply-and-offer balance is disturbed, leading to myocardial ischemia. If atherosclerotic plaques become unstable and local thrombosis develops, a myocardial infarction occurs. Sometimes, myocardial ischemia and infarction may result in significant and irreversible heart failure. To prevent severe complications, such as acute coronary syndromes and ischemia-related heart failure, extensive efforts have been made for developing biomarkers that would help identify patients at increased risk for cardiovascular events. In this two-part study, we attempted to provide a review of existing knowledge of blood biomarkers that may be used in this setting. The first part of this work was dedicated to conventional biomarkers, which are already used in clinical practice. In the second part, here presented, we discuss emerging biomarkers which have not yet become mainstream.Keywords
This publication has 115 references indexed in Scilit:
- Copeptin is an independent predictor of diabetic heart disease and deathAmerican Heart Journal, 2015
- Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failureJournal of Internal Medicine, 2014
- Iron deficiency and health-related quality of life in chronic heart failure: Results from a multicenter European studyInternational Journal of Cardiology, 2014
- Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarctionEuropean Journal of Preventive Cardiology, 2014
- Hypoalbuminemia in Acute Heart Failure Patients: Causes and Its Impact on Hospital and Long-Term MortalityJournal of Cardiac Failure, 2014
- A 2-Year Follow-Up of Oxidative Stress Levels in Patients With ST-Segment Elevation Myocardial InfarctionAngiology, 2014
- Thyroid Hormone and the Cardiovascular SystemMedical Clinics of North America, 2012
- NGAL: a biomarker of acute kidney injury and other systemic conditionsInternational Urology and Nephrology, 2009
- Uric Acid: The Oxidant-Antioxidant ParadoxNucleosides, Nucleotides & Nucleic Acids, 2008
- YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosisInflammation Research, 2006